Baltimore, MDNCT05977179Now EnrollingIRB Ready

Post-Acute COVID-19 Syndrome Clinical Trial in Baltimore, MD

Access cutting-edge post-acute covid-19 syndrome treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by University of Maryland, Baltimore

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access post-acute covid-19 syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related post-acute covid-19 syndrome treatment provided free

Apply for This Baltimore Location

Check if you qualify for this post-acute covid-19 syndrome clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Post-Acute COVID-19 Syndrome Study in Baltimore

The primary objective of this study is to conduct a 16-week randomized controlled trial aimed at investigating the effectiveness of the Whole-Diet Approach when following a healthy US-style diet rich in anti-inflammatory properties. The study will focus on evaluating its impact on reducing symptoms related to Post-Acute Sequelae of SARS-CoV-2 Infection (PACS) in adults aged 50 years and older. The main research questions this study aims to answer are: 1. Does adhering to a healthy US-style diet, which is abundant in anti-inflammatory properties, effectively mitigate fatigue symptoms in adults with PACS? 2. Does adhering to a healthy US-style diet, which is abundant in anti-inflammatory properties, effectively mitigate declines in muscle function and physical performance in adults with PACS? At the beginning of the study, eligible participants will be randomly assigned to either the Dietary Intervention Group, where they will receive personalized dietary plans and weekly sessions, or the Attention Control Group, where they will attend general health sessions on a weekly basis as well. This research intends to shed light on the potential benefits of the Whole-Diet Approach and its role in ameliorating PACS-related symptoms among older adults. By comparing the outcomes of the two groups, we hope to gain valuable insights into the effectiveness of this dietary intervention in improving the quality of life for individuals dealing with PACS.

Sponsor: University of Maryland, Baltimore

Who Can Participate

Inclusion Criteria

Age of 50 years or older
No known active infectious disease (COVID-19 or other).
Participant diagnosed with long-COVID/ post- acute COVID-19 syndrome (PACS) /ICD-10-CM codes U09.9
Moderate/severe fatigue Brief Fatigue Inventory (BFI)≥4
Poor diet quality assessed by the short Healthy Eating Index (HEI)\<70

Exclusion Criteria

Participants with a home oxygen requirement or requiring chronic ventilator support
Participants diagnosed with diabetes who do not have a recent HbA1c level or with HbA1c \> 9%
Participants diagnosed with Congestive Heart Failure (CHF New York Heart Association) \> class 2
Participants with dietary restrictions due to medication use that affects blood clotting, such as Warfarin or other reasons.
Evidence of any condition as determined by a physician or the study team that would lead to an increased risk of illness due to any aspect of proposed testing and interventions, or introduce unanticipated confounding of study results.
Participants diagnosed with uncontrolled hypertension that will be defined as:
Systolic blood pressure consistently equal to or higher than 190 mmHg.
Diastolic blood pressure consistently equal to or higher than 110 mmHg.
Participants with a recent history of hypertensive crisis (severe elevation in blood pressure requiring immediate medical intervention), regardless of current blood pressure levels.
Participants with diet restrictions or allergies that can affect adherence to the diet, such as allergy to fish or shellfish.
Participation in another trial in which active intervention is being received.
Participants with active drug or alcohol use/dependence that would interfere with adherence to the study.
Participants scheduled for surgical procedures within the next 6 months.
Participants diagnosed with active cancer.
Participants diagnosed with liver diseases.
Participants diagnosed with kidney-related conditions, including Chronic Kidney Disease (CKD) \> stage 3.
Below the age of 50 years.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT05977179) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Post-Acute COVID-19 Syndrome Treatment Options in Baltimore, MD

If you're searching for post-acute covid-19 syndrome treatment options in Baltimore, MD, this clinical trial (NCT05977179) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced post-acute covid-19 syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all post-acute covid-19 syndrome clinical trials near you to find additional studies recruiting in your area.

More COVID-19 Trials in Baltimore, MD

See all covid-19 clinical trials recruiting in Baltimore — not just this study.

Browse COVID-19 Trials in Baltimore

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD